Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1250, pseudogene (RNU6-1250P), is a human pseudogene located on chromosome 10 (GRCh38: 67,808,502-67,808,608)[1][3][7][9]. It does not code for a functional protein or small nuclear RNA, but is instead a non-coding genomic sequence related to functional U6 snRNA genes, representing an inactivated (nonfunctional) copy or processed pseudogene[1][3][4][7][9]. Like other U6 snRNA pseudogenes, it originates from the U6 small nuclear RNA gene but has lost its function; such pseudogenes are generated through retrotransposition events and can be used as genomic markers of retrotransposition dynamics in mammals[4]. RNU6-1250P has no established role as a therapeutic target, no described involvement in drug action or disease, and no known significance as a biomarker in clinical contexts[1][3][7][9]. Key details: - It is not a protein-coding gene or functional RNA. - Not considered a target for therapeutic intervention. - No known direct biological function, disease role, or use as a biomarker or drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1250, pseudogene (RNU6-1250P).